OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Molecular Characterization ofKRASWild-type Tumors in Patients with Pancreatic Adenocarcinoma
Philip A. Philip, Ibrahim Azar, Joanne Xiu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2704-2714
Open Access | Times Cited: 117
Philip A. Philip, Ibrahim Azar, Joanne Xiu, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 12, pp. 2704-2714
Open Access | Times Cited: 117
Showing 26-50 of 117 citing articles:
GERMLINE PATHOGENIC VARIANTS IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA AND EXTRA-PANCREATIC MALIGNANCIES: A NATIONWIDE DATABASE ANALYSIS
Valentyna Kryklyva, Michael J. Pflüger, Hicham Ouchene, et al.
Modern Pathology (2025), pp. 100709-100709
Open Access
Valentyna Kryklyva, Michael J. Pflüger, Hicham Ouchene, et al.
Modern Pathology (2025), pp. 100709-100709
Open Access
Evaluation of the Value of Fine Needle Aspiration Cytology and Cell Morphology in Determining the Histogenesis of Pancreatic Lesions With Review of Literature, Overview and Cytological Experience of 25 Years: Original Research
B. Soudah, Mahmoud Abbas
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access
B. Soudah, Mahmoud Abbas
Health Science Reports (2025) Vol. 8, Iss. 1
Open Access
Pancreatic Ductal Adenocarcinoma with Medullary Features and a Complete Pathological Response After Neoadjuvant FOLFIRINOX: A Case Report and Literature Review
Rodrigo G. Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Rodrigo G. Taboada, Maria Fernanda Arruda Almeida, Karina Miranda Santiago, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Molecular Subtyping and Genomic Profiling Expand Precision Medicine in KRAS Wild‐Type Pancreatic Cancer
Dan Su, Yuli Ruan, Yingfei Shi, et al.
Cancer Science (2025)
Open Access
Dan Su, Yuli Ruan, Yingfei Shi, et al.
Cancer Science (2025)
Open Access
Leveraging Epigenetic Alterations in Pancreatic Ductal Adenocarcinoma for Clinical Applications
Jörg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Seminars in Cancer Biology (2025)
Open Access
Jörg Tost, Secil Ak-Aksoy, Daniele Campa, et al.
Seminars in Cancer Biology (2025)
Open Access
Detection of mutated KRAS, TP53, CDK2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing
Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, et al.
Research Square (Research Square) (2025)
Open Access
Anelis Maria Marin, Branca Engel Timoner, Diogo Dias Araújo, et al.
Research Square (Research Square) (2025)
Open Access
Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer
Marjolein F. Lansbergen, Mark P.G. Dings, Jan Köster, et al.
Med (2025), pp. 100601-100601
Open Access
Marjolein F. Lansbergen, Mark P.G. Dings, Jan Köster, et al.
Med (2025), pp. 100601-100601
Open Access
Molecular analysis in pancreatic adenocarcinoma: a real-world study from high-volume French centres (CAPANCOBIO study)
Camille Evrard, Mathias Brügel, Guillaume Piessen, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 7, pp. 100142-100142
Closed Access
Camille Evrard, Mathias Brügel, Guillaume Piessen, et al.
ESMO Gastrointestinal Oncology (2025) Vol. 7, pp. 100142-100142
Closed Access
Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Polysaccharides as therapeutic vehicles in pancreatic cancer
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access
Seema Kumari, Sujatha Peela, Ganji Purnachandra Nagaraju, et al.
Drug Discovery Today (2025), pp. 104320-104320
Closed Access
Diagnostik und Therapiekonzepte für das Pankreaskarzinom – Update 2024
Angelika Kestler, Thomas Seufferlein
Gastroenterologie up2date (2025) Vol. 21, Iss. 01, pp. 25-41
Closed Access
Angelika Kestler, Thomas Seufferlein
Gastroenterologie up2date (2025) Vol. 21, Iss. 01, pp. 25-41
Closed Access
Prolonged response to osimertinib in three patients with refractory metastatic pancreatic adenocarcinomas with EGFR exon 19 deletion: a case report and literature review
Timothée Vigié, Alexandre Perrier, Brice Chanez, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Timothée Vigié, Alexandre Perrier, Brice Chanez, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Diagnostik und Therapiekonzepte für das Pankreaskarzinom – Update 2024
Angelika Kestler, Thomas Seufferlein
TumorDiagnostik & Therapie (2025) Vol. 46, Iss. 03, pp. 176-190
Closed Access
Angelika Kestler, Thomas Seufferlein
TumorDiagnostik & Therapie (2025) Vol. 46, Iss. 03, pp. 176-190
Closed Access
Precision Oncology in Pancreatic Cancer and Future Treatment Directions
Layal Al Mahmasani, Eileen M. O’Reilly
Surgical Oncology Clinics of North America (2025)
Closed Access
Layal Al Mahmasani, Eileen M. O’Reilly
Surgical Oncology Clinics of North America (2025)
Closed Access
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database
Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, et al.
Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 145-156
Closed Access | Times Cited: 12
Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, et al.
Journal of Gastroenterology (2023) Vol. 59, Iss. 2, pp. 145-156
Closed Access | Times Cited: 12
Advances in the role of SWI /SNF complexes in tumours
Ziwei Li, Jiumei Zhao, Yu Tang
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 8, pp. 1023-1031
Open Access | Times Cited: 11
Ziwei Li, Jiumei Zhao, Yu Tang
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 8, pp. 1023-1031
Open Access | Times Cited: 11
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Maria Urbanova, Marina Cihova, Verona Buociková, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115179-115179
Open Access | Times Cited: 11
Maria Urbanova, Marina Cihova, Verona Buociková, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115179-115179
Open Access | Times Cited: 11
Recent Advances in Targeting Histone H3 Lysine 36 Methyltransferases for Cancer Therapy
Sai Ma, Guanlu Long, Zheng Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116532-116532
Closed Access | Times Cited: 4
Sai Ma, Guanlu Long, Zheng Jiang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116532-116532
Closed Access | Times Cited: 4
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Oncogenic gene fusions in cancer: from biology to therapy
Stephen V. Liu, Misako Nagasaka, Judith Atz, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Stephen V. Liu, Misako Nagasaka, Judith Atz, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 16
Brandon M. Huffman, Haley Ellis, Alexander C. Jordan, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 16
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy
Raefa Abou Khouzam, Jean‐Maríe Lehn, Hemma Mayr, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1235-1235
Open Access | Times Cited: 10
Raefa Abou Khouzam, Jean‐Maríe Lehn, Hemma Mayr, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1235-1235
Open Access | Times Cited: 10
Endoscopic Ultrasound-Guided Tissue Acquisition of Pancreaticobiliary Cancer Aiming for a Comprehensive Genome Profile
Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1275-1275
Open Access | Times Cited: 10
Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, et al.
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1275-1275
Open Access | Times Cited: 10
